Pricing Log in Create free account

Dermata Therapeutics, Inc. (DRMA) vs NuCana PLC Sponsored ADR (NCNA)

Dermata Therapeutics, Inc. and NuCana PLC Sponsored ADR are both Biotechnology companies. Dermata Therapeutics, Inc. and NuCana PLC Sponsored ADR are of similar size ($4.0M and $3.8M). Across the 10 metrics below, NuCana PLC Sponsored ADR leads on 6 and Dermata Therapeutics, Inc. on 4.

Valuation

Metric DRMA NCNA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.89 0.14 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.07 1.24 0.66
EV/Sales n/m n/m 9.02
Earnings yield (585.53%) (12,777.07%) (32.88%)
Free cash flow yield (259.42%) (179.93%) (23.13%)

Profitability

Metric DRMA NCNA Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (183.89%) (68.70%) (51.96%)
Return on assets (139.93%) (45.24%) (46.06%)
Return on invested capital 0.00% (1,130.23%) 0.00%

Growth

Metric DRMA NCNA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 89.84% 98.95% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DRMA NCNA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.81 4.73 4.97
Net debt to EBITDA 0.97 1.23 1.01

Dividend

Metric DRMA NCNA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DRMA NCNA Biotechnology median
Market cap 3.78m 4.03m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack